VNRX Latest Headlines

VNRX Moves Toward French Reimbursement Milestone as Nu.Q® Cancer Assays Gain Institutional Backing

Market Chameleon (Fri, 30-Jan 11:45 AM)

VolitionRx Highlights Nu.Q® Vet Cancer Test at VMX 2026 Symposium: Early Detection in Veterinary Medicine Takes Center Stage

Market Chameleon (Tue, 20-Jan 11:07 AM)

VolitionRx Secures $2 Million Financing: What the Amended Deal Reveals About Future Prospects

Market Chameleon (Thu, 8-Jan 10:33 AM)

VolitionRx Charts Transformational Year: Landmark Licensing Deals, Breakthroughs in Cancer and Sepsis Detection Signal Strategic Momentum

Market Chameleon (Wed, 17-Dec 9:55 AM)